ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,909.03
      -1.11%
      US Tech 100
      20,592.00
      -0.07%
      Dow Jones
      42,528.36
      -0.42%
      Brent Oil
      77.155
      0.12%
      Bitcoin
      95,103.66
      -1.86%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Neurones Sa (0GX2) Quote

      Neurones Sa

      Neurones Sa (0GX2)

      LSE
      25.90
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      25.90
      Bid
      0.00
      Ask
      0.00
      Volume
      0.00
      0.00 Day's Range 0.00
      25.90 52 Week Range 25.90
      Market Cap
      628.826M
      Previous Close
      25.90
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      118
      Shares Outstanding
      24,279,000
      Dividend Yield
      -
      PE Ratio
      22.26
      Earnings Per Share (EPS)
      2.04
      Revenue
      743.71M
      Net Profit
      49.41M

      About Neurones Sa

      Sector
      Computer Programming Service
      Industry
      Computer Programming Service
      Website
      www.neurones.net
      Headquarters
      Nanterre, Hauts-de-seine, Fra
      Founded
      -
      Neurones Sa is listed in the Computer Programming Service sector of the London Stock Exchange with ticker 0GX2. The last closing price for Neurones was 25.90 €. Over the last year, Neurones shares have traded in a share price range of 25.90 € to 25.90 €.

      Neurones currently has 24,279,000 shares outstanding. The market capitalization of Neurones is 628.83 € million. Neurones has a price to earnings ratio (PE ratio) of 22.26.

      Ask ADVFN Intelligence (AI)

      0GX2 Latest News

      More News

      FeaturedEzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion

      23 hours ago

      Neurones: Organic growth up 10.5% in 3rd quarter 2024

      Neurones: Organic growth up 10.5% in 3rd quarter 2024 PRESS INFORMATIONHeading: 3rd quarter 2024 revenues        Nanterre, November 6, 2024 (after trading) Organic growth up 10.5% in 3rd quarter...

      November 06 2024
      UK Regulatory

      NEURONES : + 10,5% de croissance organique au 3e trimestre 2024

      NEURONES : + 10,5% de croissance organique au 3e trimestre 2024 INFORMATION PRESSERubrique : C.A. 3e trimestre 2024        Nanterre, le 6 novembre 2024 (après Bourse) + 10,5% de croissance...

      November 06 2024
      UK Regulatory

      NEURONES - Rapport financier premier semestre 2024

      NEURONES - Rapport financier premier semestre 2024 NEURONES-rapport-financier-premier-semestre-2024 Pièce jointe NEURONES-rapport-financier-premier-semestre-2024

      September 13 2024
      UK Regulatory

      NEURONES : 7,3% de résultat net au 1er semestre 2024

      NEURONES : 7,3% de résultat net au 1er semestre 2024 INFORMATION PRESSERubrique : Résultats 1er semestre 2024        Nanterre, le 11 septembre 2024 (après Bourse) 7,3% de résultat net au 1er...

      September 11 2024
      UK Regulatory

      Neurones: 7.3% net profit in 1st half 2024

      Neurones: 7.3% net profit in 1st half 2024 PRESS INFORMATIONHeading: 1st half 2024 results        Nanterre, September 11, 2024 (after trading) 7.3% net profit in 1st half 2024 (in millions of...

      September 11 2024
      UK Regulatory

      NEURONES : + 9,1% de croissance au 1er semestre 2024

      NEURONES : + 9,1% de croissance au 1er semestre 2024 INFORMATION PRESSE        Nanterre, le 7 août 2024 (après Bourse)Rubrique : C.A. 1er semestre 2024 + 9,1% de croissance au 1er semestre 2024...

      August 07 2024
      UK Regulatory

      NEURONES: Growth up 9.1% in 1st half 2024

      NEURONES: Growth up 9.1% in 1st half 2024 PRESS INFORMATION        Nanterre, August 7, 2024 (after trading)Heading: 1st half 2024 revenues Growth up 9.1% in 1st half 2024 in millions of eurosH1...

      August 07 2024
      UK Regulatory

      NEURONES : Descriptif du programme de rachat d'actions

      NEURONES : Descriptif du programme de rachat d'actions INFORMATION PRESSERubrique : Rachat d’actions        Nanterre, le vendredi 7 juin 2024 (après Bourse) DESCRIPTIF DU PROGRAMME DE...

      June 07 2024
      GlobeNewswire Inc.

      NEURONES : + 8,6% de croissance organique au 1er trimestre 2024

      NEURONES : + 8,6% de croissance organique au 1er trimestre 2024 INFORMATION PRESSERubrique : C.A. 1er trimestre 2024        Nanterre, le 15 mai 2024 (après Bourse) + 8,6% de croissance...

      May 15 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10025.925.925.95225.9DE
      40025.925.925.98725.9DE
      120025.925.925.911825.9DE
      260025.925.925.98225.9DE
      520025.925.925.930425.9DE
      1560025.925.925.922425.9DE
      2600025.925.925.933625.9DE

      0GX2 - Frequently Asked Questions (FAQ)

      What is the current Neurones share price?
      The current share price of Neurones is 25.90 €
      How many Neurones shares are in issue?
      Neurones has 24,279,000 shares in issue
      What is the market cap of Neurones?
      The market capitalisation of Neurones is EUR 628.83M
      What is the 1 year trading range for Neurones share price?
      Neurones has traded in the range of 25.90 € to 25.90 € during the past year
      What is the PE ratio of Neurones?
      The price to earnings ratio of Neurones is 22.26
      What is the cash to sales ratio of Neurones?
      The cash to sales ratio of Neurones is 1.48
      What is the reporting currency for Neurones?
      Neurones reports financial results in EUR
      What is the latest annual turnover for Neurones?
      The latest annual turnover of Neurones is EUR 743.71M
      What is the latest annual profit for Neurones?
      The latest annual profit of Neurones is EUR 49.41M
      What is the registered address of Neurones?
      The registered address for Neurones is IMMEUBLE LE CLEMENCEAU 1, 205, AVENUE GEORGES CLEMENCEAU, NANTERRE, HAUTS-DE-SEINE, 92024
      What is the Neurones website address?
      The website address for Neurones is www.neurones.net
      Which industry sector does Neurones operate in?
      Neurones operates in the COMPUTER PROGRAMMING SERVICE sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GRIOGround Rents Income Fund Plc
      31.50p
      (37.55%)
      		68.95k
      N4PN4 Pharma Plc
      0.65p
      (23.81%)
      		9.26M
      ROCKRockfire Resources Plc
      0.195p
      (21.88%)
      		37.02M
      MKAMkango Resources Ltd
      11.00p
      (18.28%)
      		3.95M
      VRSVersarien Plc
      0.04p
      (14.29%)
      		17.62M
      RBGPRbg Holdings Plc
      1.625p
      (-38.10%)
      		1.99M
      AGTAAgriterra Ld
      0.75p
      (-15.73%)
      		5.5k
      PPSProton Motor Power Systems Plc
      0.275p
      (-15.38%)
      		126.17k
      PYXPyx Resources Limited
      2.30p
      (-11.54%)
      		2.69M
      SYMESupply@me Capital Plc
      0.0032p
      (-11.11%)
      		156.39M
      TRPTower Resources Plc
      0.037p
      (-5.13%)
      		374.44M
      NTVONativo Resources Plc
      0.0019p
      (0.00%)
      		291.38M
      DGIDg Innovate Plc
      0.0185p
      (-7.50%)
      		159.4M
      SYMESupply@me Capital Plc
      0.0032p
      (-11.11%)
      		156.39M
      GBPGlobal Petroleum Limited
      0.205p
      (-6.82%)
      		117.3M

      Discussion

      View Full Feed
      Methinks Methinks 3 minutes ago
      https://abcnews.go.com/International/wireStory/japan-links-chinese-hacker-mirrorface-dozens-cyberattacks-targeting-117452466
      They can trace them but by using Wave, they should stop them.
      jimr1717 jimr1717 4 minutes ago
      🏆️Filed a Form S-1 Registration Statement,
      are offering shares of the Company's common stock to the public.
      As soon as practicable after the effective date of this Registration Statement.

      PROSPECTUS
      All Things Mobile Analytic, Inc.
      30,000,000 Shares
      ATMH
      Konaploinks Konaploinks 4 minutes ago
      Right. The little ego maniac wasn’t getting all the attention anymore boo hoo hoo. Everyone was dumping his hype and investing in the future. Quantum is here and now and and he knows it and is scared to death. He’s seen his investors like myself pull out in droves and make 400% other money instead o
      IONQ
      nelson1234 nelson1234 4 minutes ago
      HALO raises '25 guidance, and new 'accelerated' share repurchase

      Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance
      Jan. 08, 2025 7:00 AM ET Halozyme Therapeutics, Inc. (HALO)
      Reports Preliminary 2024 Unaudited Estimated Ranges
      Babubd Babubd 5 minutes ago
      To da moon any day!
      ELAB
      RIGATONI RIGATONI 6 minutes ago
      .135 on 113M already, crazy ~Rig
      ttottip ttottip 6 minutes ago
      Anyway the quantum computers are the future of the computers.
      QUBT
      luvwetscent luvwetscent 7 minutes ago
      Fact or opinion?
      ELTP
      LowFloatLopes LowFloatLopes 8 minutes ago
      Down a lot ..still worth grabbing???
      DATS
      mahatmapaul mahatmapaul 8 minutes ago
      Gshores Wrote the following back in May when the PPS was at its height:
      someone is loading up at .0129, not sure if its MM's or shorts or big investor, but the wall is there for a reason, going to blow up soon imo. love this company!
      Why anybody would take such a fool seriously is beyo
      SPZI
      Risk vs Reward Risk vs Reward 8 minutes ago
      This will be pretty volitile for the next few months...

      Until we see some revenue contracts that exceed testing money no one will be happy... 

      Plus I figure we're 2 Q's away from being profitable... 

      Exceptional company products and management 
      Top
      KULR
      StayHumble StayHumble 10 minutes ago
      🇺🇸Hearing a MOASS takes $DJT to MARS!🇺🇸wow🇺🇸🇺🇸🇺🇸
      DJT
      floblu14 floblu14 11 minutes ago
      As Dew stated :
      Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
      Jan 08, 2025

      WATERTOWN, Mass.--(BUSINESS WIRE)--Jan. 8, 2025-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating
      ENTA
      Debunkinator Debunkinator 11 minutes ago
      "We've dramatically strengthened our financial health, improving our shareholder equity from approximately -$7.164M to -$1.176M. This significant balance sheet cleanup, including the elimination of all outstanding convertible debt, provides a solid foundation for aggressive growth".
      ASII
      NASDAQ2020 NASDAQ2020 12 minutes ago
      Vyvanse Quota going Fast.
      ELTP
      Mufaso Mufaso 12 minutes ago
      I can't even think of a reason not to PR this data.

      There are competitive reasons not to release details on these studies if your goal is to minimize copycats.
      Bubae Bubae 12 minutes ago
      The new Chief Financial Officer, Daniel Gilcher, has already been discredited. The guy is peddling 2023 numbers while knowing the company's financials and stock has plummeting since. Their year over year revenue for the first half of 2024 was down 71%. Net profit down 434% with a negative EBITA per
      RDAR
      Crazyj Crazyj 14 minutes ago
      What you takin about Williis
      GTCH
      RIGATONI RIGATONI 14 minutes ago
      .121 bought the dip ~Rig
      Mufaso Mufaso 15 minutes ago
      The PR could also be intended to facilitate a financing round.

      Yes, Good point. FYI- Metsera is already pretty well funded. They already got an initial $350 million to start the company which they used partially to buy up some Korean compounds and attract some well known (very highly
      Tahoe2468 Tahoe2468 15 minutes ago

      Trend lines don't lie! Gonna be a Banger day with PR news please don't sell on news if it's positive like DUH... 😂🤦🏻‍♂️🤦🏻‍♂️🤦dz
      KRTL
      WebSlinger WebSlinger 15 minutes ago
      >

      I was being kind when I said that it was about 5-10 years away....

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175443221
      QUBT
      Tahoe2468 Tahoe2468 17 minutes ago

      Trendline looks insane!!!! 
      PennyMillions852 PennyMillions852 17 minutes ago
      lol, you know I was being sarcastic.
      IGPK

      Your Recent History

      LSE
      0GX2
      Neurones
      EU
      NL0011613542
      Netherlands Government/t...
      BIT
      F17444
      Vontobel Financial Produ...
      BIT
      SSP500
      SG Issuer Societe Generale
      BIT
      W4JLD0
      UBS
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads